Dipika Bansal

National Institute of Pharmaceutical Education and Research (NIPER). S.A.S. Nagar, India

Poster(s):

• (A-228) Adverse Pulmonary Reactions Associated with Proteasome Inhibitors in Multiple Myeloma: A Disproportionality Analysis of the FDA Adverse Event Reporting System
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-118) Comparative Efficacy and Safety of Acalabrutinib Monotherapy in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-103) Comparative efficacy and safety of CFTR modulators for people with cystic fibrosis with phe508del mutation: a systematic review and bayesian network meta-analysis
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-109) Effectiveness and Tolerability of Cannabidiol in Children with Drug-Resistant Epilepsy: A Real-world Multicentric Ambispective Study in India
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLA-056) Neurological Adverse Events Associated with Valbenazine in Tardive Dyskinesia: A Meta-Analysis of Randomized Controlled Trials and FAERS Based Disproportionality Analysis
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET

• (C-182) Sight-threatening Eye Disorders in Patients Treated with Semaglutide : A Disproportionality Analysis Using the FAERS Database
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET